All In MedTech

Device Trial Radar · NCT01403077

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions

A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions

Last checked: Nov 20, 2026Latest source record: Sep 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

46

Actual

Start

Oct 2011

Primary completion

Mar 2014

Study completion Oct 2015

Sponsor

Lead sponsor
480 BiomedicalNot on our public-company list
Sponsor type
Industry
First posted
Jul 27, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an initial evaluation of the 480 Biomedical Bioresorbable Scaffold System for the treatment of subjects with de novo native superficial femoral artery lesions.

Conditions

  • Superficial Femoral Artery Lesions
  • Atherosclerosis of Femoral Artery

Interventions

  • 480 Biomedical Bioresorbable Scaffold SystemDevice

    480 Biomedical Bioresorbable Scaffold System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major adverse events at 6 months post procedureTime frame: 6 Months

Locations

6 sites in 4 countries. Site status is shown where the registry gives one.

  • The Alfred

    Melbourne, Australia

  • Universitäts Klinikum Graz

    Graz, Austria

  • Universitaet Freiburg-Bad Krozingen

    Freiburg im Breisgau, Germany

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.